NCT01232595 - Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections | Biotech Hunter

Enrollment

109

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions

Moderate Clostridium Difficile Infection

Interventions

DRUG

LFF571

DRUG

Vancomycin (POC)

Trial Locations (18)

27710

Novartis Investigative Site, Durham

29425

Novartis Investigative Site, Charleston

30030

Novartis Investigative Site, Decatur

33756

Novartis Investigative Site, Clearwater

43215

Novartis Investigative Site, Columbus

46360

Novartis Investigative Site, Michigan City

59701

Novartis Investigative Site, Butte

60637

Novartis Investigative Site, Chicago

66606

Novartis Investigative Site, Topeka

73112

Novartis Investigative Site, Oklahoma City

78212

Novartis Investigative Site, San Antonio

83404

Novartis Investigative Site, Idaho Falls

92211

Novartis Investigative Site, Palm Desert

06010

Novartis Investigative Site, Bristol

L8N 4A6

Novartis Investigative Site, Hamilton

G7H 5H6

Novartis Investigative Site, Chicoutimi

H1T 2M4

Novartis Investigative Site, Montreal

G8Z 3R9

Novartis Investigative Site, Trois-Rivières